Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
Funds
Overview
Currencies
International
Treasuries
Monopar Therapeutics Inc
(NQ:
MNPR
)
16.66
-0.22 (-1.30%)
Streaming Delayed Price
Updated: 4:00 PM EST, Nov 11, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
103,213
Open
17.40
Bid (Size)
16.20 (1)
Ask (Size)
17.00 (4)
Prev. Close
16.88
Today's Range
16.50 - 17.55
52wk Range
1.369 - 38.50
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Monopar Therapeutics Reports Third Quarter 2024 Financial Results and Recent Developments
November 08, 2024
From
Monopar Therapeutics Inc.
Via
GlobeNewswire
Monopar Therapeutics Inc. Announces Pricing of $19.2 Million Public Offering of Common Stock
October 28, 2024
From
Monopar Therapeutics Inc.
Via
GlobeNewswire
Performance
YTD
+800.54%
+800.54%
1 Month
+209.09%
+209.09%
3 Month
+607.43%
+607.43%
6 Month
+393.56%
+393.56%
1 Year
+967.61%
+967.61%
More News
Read More
12 Health Care Stocks Moving In Monday's After-Market Session
October 28, 2024
Via
Benzinga
Monopar Therapeutics Inc. Announces Proposed Public Offering of Common Stock
October 28, 2024
From
Monopar Therapeutics Inc.
Via
GlobeNewswire
12 Health Care Stocks Moving In Monday's Pre-Market Session
October 28, 2024
Via
Benzinga
Why LENZ Therapeutics Shares Are Trading Higher By Around 18%; Here Are 20 Stocks Moving Premarket
October 28, 2024
Via
Benzinga
MarketBeat Week in Review – 10/21- 10/25
October 26, 2024
Via
MarketBeat
Topics
Artificial Intelligence
Economy
Stocks
Exposures
Artificial Intelligence
Economy
Interest Rates
12 Health Care Stocks Moving In Friday's Intraday Session
October 25, 2024
Via
Benzinga
What's Going On With Monopar Therapeutics Shares Friday?
October 25, 2024
Via
Benzinga
Monopar Therapeutics Skyrockets 400% on Licensing Deal
October 25, 2024
Via
MarketBeat
Exposures
COVID-19
12 Health Care Stocks Moving In Friday's Pre-Market Session
October 25, 2024
Via
Benzinga
Why Deckers Outdoor Shares Are Trading Higher By Around 14%; Here Are 20 Stocks Moving Premarket
October 25, 2024
Via
Benzinga
Monopar Therapeutics, Intellia Therapeutics, Capri Holdings, Western Digital, And Tesla: Why These 5 Stocks Are On Investors' Radars Today
October 24, 2024
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Monopar Therapeutics Stock Jumps 4X, Inks Licensing Pact With AstraZeneca For Once Terminated Phase 3 Candidate For Rare Genetic Disorder
October 24, 2024
Via
Benzinga
Monopar Announces Agreement with Alexion, AstraZeneca Rare Disease For Late-Stage Wilson Disease Drug Candidate
October 24, 2024
From
Monopar Therapeutics Inc.
Via
GlobeNewswire
Monopar Presents Encouraging Human Clinical Dosimetry Data on its uPAR Program at EANM 2024
October 22, 2024
From
Monopar Therapeutics Inc.
Via
GlobeNewswire
Monopar Expands Radiopharma Intellectual Property Portfolio with Patent Filing on New Compounds and Linkers
October 15, 2024
From
Monopar Therapeutics Inc.
Via
GlobeNewswire
Monopar Initiates Clinical Trial of Novel uPAR-Targeted Radiopharmaceutical Therapy in Advanced Cancers
October 07, 2024
From
Monopar Therapeutics Inc.
Via
GlobeNewswire
12 Health Care Stocks Moving In Tuesday's Intraday Session
October 01, 2024
Via
Benzinga
Why Monopar Therapeutics (MNPR) Stock Is Skyrocketing Today
September 12, 2024
Via
Benzinga
Monopar Announces Positive Early Human Clinical Data Validating the Tumor Targeting Ability of MNPR-101-Zr
September 12, 2024
From
Monopar Therapeutics Inc.
Via
GlobeNewswire
Monopar to Participate in the H.C. Wainwright 26th Annual Global Investment Conference
September 04, 2024
From
Monopar Therapeutics Inc.
Via
GlobeNewswire
Monopar Regains Compliance with Nasdaq Minimum Bid Price Rule
August 27, 2024
From
Monopar Therapeutics Inc.
Via
GlobeNewswire
Monopar Receives Clearance to Proceed with Phase 1 Therapeutic Trial of Novel Radiopharmaceutical in Advanced Cancers
August 21, 2024
From
Monopar Therapeutics Inc.
Via
GlobeNewswire
Monopar Announces Initial Data for First Patient Dosed in Radiopharma Phase 1 Clinical Trial of MNPR-101-Zr
August 14, 2024
From
Monopar Therapeutics Inc.
Via
GlobeNewswire
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.